About Otakeganka Tsukimino Clinic
Clinical Trials at Otakeganka Tsukimino Clinic
During the past decade, Otakeganka Tsukimino Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Otakeganka Tsukimino Clinic"
#1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Otakeganka Tsukimino Clinic
According to Clinical.Site data, the most researched conditions in "Otakeganka Tsukimino Clinic" are
"Macular Degeneration" (1 trials) and "Neovascular Age-Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Otakeganka Tsukimino Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Otakeganka Tsukimino Clinic
Most popular intervention types in "Otakeganka Tsukimino Clinic" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abicipar Pegol" (1 trials), "Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)" (1 trials), "Aflibercept VEGF Trap-Eye (Eylea, BAY86-5321)" (1 trials), "Ranibizumab" (1 trials) and "Sham Procedure" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Otakeganka Tsukimino Clinic
The vast majority of trials in "Otakeganka Tsukimino Clinic" are
2 trials for "All" genders.
Clinical Trials Status at Otakeganka Tsukimino Clinic
Currently, there are NaN active trials in "Otakeganka Tsukimino Clinic".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Otakeganka Tsukimino Clinic,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Otakeganka Tsukimino Clinic, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".